This week, our science reporter Tom Feilden has been reporting on new developments in genetic research into cancer that could lead to more effective drug treatments. Head of the Scottish Medicines Consortium Ken Patterson discusses the hard choices to be made over funding drug research.

Get in touch with Today via email , Twitter or Facebook or text us on 84844.